Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Basic study of chemo-embolization of the liver using hydroxyapatite granules].

M Tsugita1, S Tsuru, K Takasaki

  • 1Dept. of Microbiology, National Defense Medical College.

Gan to Kagaku Ryoho. Cancer & Chemotherapy
|October 1, 1989
PubMed
Summary

Hydroxyapatite (HAp) granules show promise as a chemoembolic agent. This study found HAp enhanced drug retention in the liver while reducing liver enzyme levels, suggesting a safe and effective clinical application.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A comparison of thyroidal protection by iodine and perchlorate against radioiodine exposure in Caucasians and Japanese.

Archives of toxicology·2021
Same author

Identification of ABCG2 as an Exporter of Uremic Toxin Indoxyl Sulfate in Mice and as a Crucial Factor Influencing CKD Progression.

Scientific reports·2018
Same author

CYFRA 21-1 as a tumor marker for squamous cell carcinoma of the esophagus.

Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus·2017
Same author

High-temperature-required protein A2 as a predictive marker for response to chemotherapy and prognosis in patients with high-grade serous ovarian cancers.

British journal of cancer·2016
Same author

Photodynamic therapy mediates innate immune responses via fibroblast-macrophage interactions.

Human cell·2015
Same author

High-temperature-required protein A2 as a predictive marker for response to chemotherapy and prognosis in patients with high-grade serous ovarian cancers.

British journal of cancer·2015

Area of Science:

  • Biomaterials Science
  • Oncology
  • Radiology

Background:

  • Chemoembolization therapy is a crucial treatment for liver cancer.
  • Developing effective and safe embolic agents is essential for improving treatment outcomes.

Purpose of the Study:

  • To evaluate hydroxyapatite (HAp) granules as a potential chemoembolic agent.
  • To assess the efficacy and safety of HAp in delivering adriamycin (ADM) for chemoembolization.

Main Methods:

  • Adriamycin (ADM) mixed with HAp granules or Lipiodol was administered via hepatic artery in Wistar rats.
  • ADM concentration in liver and serum transaminase levels were monitored serially.

Main Results:

  • Higher residual ADM concentration was observed in the liver with HAp granules compared to controls.

Related Experiment Videos

  • Serum transaminase levels were significantly lower in the HAp groups, indicating reduced liver toxicity.

    • Conclusions:

    • HAp granules demonstrate favorable characteristics for chemoembolization, including biocompatibility and detectability.
    • The drug-carrying capacity and safety profile suggest HAp is a viable candidate for clinical chemoembolization therapy.